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Abstract
Background: The cytokine IL-10 and its family members have been implicated in autoimmune diseases and we have
previously reported that genetic variants in IL-10 were associated with a rare group of diseases called juvenile idiopathic
arthritis (JIA). The aim of this study was to fine map genetic variants within the IL-10 cytokine family cluster on chromosome
1 using linkage disequilibrium (LD)-tagging single nucleotide polymorphisms (tSNPs) approach with imputation and
conditional analysis to test for disease associations.
Methodology/Principal Findings: Fifty-three tSNPs were tested for association between Caucasian paediatric cohorts [219
systemic JIA (sJIA), 187 persistent oligoarticular JIA (pOJIA), and 139 extended OJIA (eOJIA) patients], and controls
(Wellcome Trust control cohort, WTCCC2). Significant association with sJIA was detected at rs1400986 in the promoter of IL-
20 (odds ratio 1.53; 95% CI 1.21–1.93; p = 0.0004), but in no other subtypes. Imputation analysis identified additional
associated SNPs for pOJIA at IL-20 and IL-24, including a rare, functional, missense variant at IL-24 with a p= 0.0002.
Penalised logistic regression analysis with HyperLasso and conditional analysis identified several further associations with
JIA subtypes. In particular, haplotype analysis refined the sJIA association, with a joint effect at rs1400986 and rs4129024 in
intron 1 of MAPKAPK2 (p = 3.2E25). For pOJIA, a 3-SNP haplotype including rs1878672 in intron 3 of IL-10 showed evidence
for association (p = 0.0018). In eOJIA, rs10863962 (39UTR of FCAMR) and rs12409577 (intron of IL-19) haplotype showed
some evidence of association (p = 0.0003).
Conclusions: This study supports previous association of IL-20 with sJIA. Haplotype analyses provided stronger association
signals than single point analyses, while a penalised logistic regression approach also suggested multiple independent
association signals. Replication studies are required to confirm or refute these findings. The results indicate that combined
effects with unknown/rare variants remain to be characterised in JIA, and represent a possible example of synthetic
association in this region.
Citation: Omoyinmi E, Forabosco P, Hamaoui R, Bryant A, Hinks A, et al. (2012) Association of the IL-10 Gene Family Locus on Chromosome 1 with Juvenile
Idiopathic Arthritis (JIA). PLoS ONE 7(10): e47673. doi:10.1371/journal.pone.0047673
Editor: Andreas Zirlik, University of Freiburg, Germany
Received April 13, 2012; Accepted September 14, 2012; Published October 18, 2012
Copyright:  2012 Omoyinmi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Arthritis Research UK and by grants from SPARKS UK [08ICH09; the Big Lottery Fund (RG/1/010135231)], and in part by
Great Ormond Street Children’s Charity. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2. A full list of the investigators
who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award
076113 and 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: e.omoyinmi@ucl.ac.uk
. These authors contributed equally to this work.
" These authors are joint senior authors.
{ Membership of the Childhood Arthritis Prospective Study (CAPS), BSPAR study group, and Childhood Arthritis Response to Medication Study (CHARMS) is
provided in the Acknowledgments.
Introduction
Juvenile idiopathic arthritis (JIA) represents a heterogeneous
group of childhood arthritides that persist for more than 6 weeks
with an onset before the age of 16 years [1]. JIA affects
approximately 1:1000 children. According to the International
League of Associations for Rheumatology (ILAR) classification
system, the disease is divided into 7 distinct clinical subtypes [1].
The groups investigated in this study are systemic JIA (sJIA)
comprising approximately 10% of all JIA, and oligoarthritis (OJIA)
which comprise approximately 40% of all JIA. OJIA is further
subdivided into persistent and extended oligoarticular JIA
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(referred to in this report as pOJIA and eOJIA respectively). If a
child has 4 or fewer joints involved at the time of study and has this
for at least 6 months they are considered to have pOJIA. However
if they ‘‘extend’’ and have more than 4 joints involved after first 6
months of disease, they are considered to have eOJIA (approx-
imately 50% of OJIA). The systemic features of sJIA make this
subtype clinically distinct from the other subtypes of JIA [2].
Evidence for differences between these subtypes is strengthened by
a recent study using mRNA profiling which showed distinct
patterns of gene expression in sJIA, compared with oligoarticular
JIA [3]. The characteristic immunological profile of sJIA is the
activation of innate immunity genes, whereas the characteristic
feature of OJIA is the strong association with the HLA class I & II
loci, which are supported by family studies [4].
Interleukin-10 (IL-10) is an important immunoregulatory
cytokine with anti-inflammatory properties. It is produced by
several cells including activated monocytes/macrophages, and
subsets of regulatory B and T cells. IL-10 is known to suppress the
release and function of a number of proinflammatory cytokines,
including IL-1b, TNF-a, and IL-6 [5]. The gene family of IL-10
consisting of IL-19, IL-20, and IL-24 are located within a highly
conserved cytokine gene cluster on chromosome 1q32. Like the
IL-4 cytokine gene cluster, recent evidence from the mouse IL-10
gene family cluster suggest that there is coordinate regulation of
these cytokines by distal regulatory elements spanning the locus
[6]. Associations with cytokine genes, in particular IL-10, are also
different between subtypes of JIA. In our previous study of the
proximal IL-10 haplotypes formed by 3 single-nucleotide poly-
morphisms (SNPs) at -1082A/G (rs1800896), -819C/T
(rs3021097), and -592A/C (rs1800872), we found an increased
frequency of the ATA haplotype in patients with eOJIA [7]. It was
demonstrated in the same study that the ATA haplotype found in
healthy individuals is associated with low IL-10 production in LPS
stimulated whole blood culture and a weaker transcriptional
activity than GCC haplotype. IL-10 production is also lower in
parents of children with eOJIA compared with those of children
with pOJIA, and have increased frequency of the ATA haplotype
when compared to controls [8].
Four SNPs (two in the IL-10 gene; one in the IL-19 gene; and
one in the IL-20) from three members of the IL-10 gene family
were examined in sJIA patients in one of our previous candidate
gene association studies [9]. Significant differences in allele
frequency were observed between cases and controls, for both
IL-10-1082 (rs1800896) (p = 0.031) and IL-20-468 (rs1400986)
(p = 0.028). Furthermore, examination of the two-SNP haplotypes
revealed stronger evidence for association (global p = 0.0006).
These genetic findings from our earlier studies, together with
the known role of IL-10 in controlling inflammation, led us to
consider the extended family of IL-10 related cytokines as
candidate genes involved with sJIA as well as OJIA. In this study
we investigated disease association of the IL-10 family of cytokines
and flanking genes in linkage disequilibrium (identified using the
Tagger function in Haploview), in a cohort comprising three
different JIA subtypes. The OJIA samples represent a different UK
cohort to our previous study. For sJIA, 122 of the 219 samples
were previously genotyped therefore this present study is an
extension of the previous cohort. Using tagging SNPs (tSNPs) that
cover a 390 Kb region, we used three different strategies to
explore the genetic contribution of the IL-10 region to JIA. Firstly,
we tested genotyped tSNPs for association with JIA subtypes using
WTCCC2 controls in a single-point analysis. Secondly, we
imputed SNPs in the 1000 genomes project and tested for
association to determine whether ungenotyped SNPs, particularly
rarer variants, showed stronger association for JIA. In order to
identify independent association signals within the region, we also
applied a penalized logistic regression approach for all typed or
imputed SNPs. Thirdly, in an exploratory analysis to determine
how multiple SNPs are associated with JIA subtypes, we perform
conditional analyses to fine map the region for haplotype-based
signals of association. These methods enable us to explore the
hypothesis of synthetic association in JIA in this region. To further
explore genetic effects in this region, expression studies were
undertaken using HapMap samples.
Results
Genotype data from a total of 545 JIA patients (219 sJIA, 187
pOJIA, 139 eOJIA) passed quality control with a call rate of
.90%. There was 100% concordance in genotype calling of
duplicate samples. Among the 68 tSNPs selected, 5 failed
genotyping and data for 53 tSNPs were available from WTCCC2
healthy individuals genotyped either by Affymetrix, or Illumina, or
both. Genotype data were available for 5723 WTCCC2 subjects,
who were used in the single point analysis. A subset of 4813
WTCCC2 controls had complete genotyping for the 53 tSNPs,
and were therefore used in the imputation, conditional and
haplotype analyses. All tSNPs included in the analysis had
genotype distributions in Hardy-Weinberg equilibrium (p-values
.0.01).
Different levels of significance were applied as appropriate for
each analysis strategy. For the single-point analysis of 53 SNPs,
Nyholt’s method [10] calculated the SNPs were equivalent to 30.9
independent tests within the region based on the LD pattern in the
WTCCC2 controls, giving a Bonferroni corrected p-value of
0.00166. The imputed SNPs were equivalent to 320 independent
tests, and a corresponding p-value of 0.00016, to retain the type 1
error at 0.05. For the exploratory conditional analysis, no
equivalent methods to determine an appropriate multiple testing
correction exist. We therefore used a threshold of suggestive
significance of p = 0.0189= 1/53 to determine which SNPs should
be added to the conditional analysis (this p-value is the level
expected to arise once in the analysis of 53 SNPs in this region).
Systemic JIA [sJIA]
This study of 219 sJIA cases detected significant association at
rs1400986, a promoter variant of IL-20 at position2468 (Figure 1)
(p = 0.0004; OR=1.53, 95% CI 1.21–1.93; Table 1). Association
at this SNP was previously described by Fife et al [9] in a smaller,
but overlapping cohort of sJIA cases. This tSNP gave the strongest
single-marker association signal across all SNPs and all JIA
subtypes. In the imputation analysis, no SNP exceeded the region-
wide p-value for significance (Figure 2; Supplementary Table S1).
Penalised logistic regression retained 4 SNPs (all imputed) in the
resulting mode (Supplementary Figure S2), although the same
evidence for association (log-posterior) was observed for several
different groups of retained SNPs (data not shown), indicating that
several different choices of SNPs could be used interchangeably.
In further analysis of the region, we conditioned on rs1400986
and analysed each SNP to detect further signals of association.
Decreased evidence for association was observed at many SNPs,
but one SNP, rs4129024, remained associated at a suggestive level
of significance (Figure 3). After conditioning on both rs1400986
(IL-20) and rs4129024 (MAPKAPK2), no additional tSNP showed
suggestive evidence for association. We then examined in more
detail the combination of the risk alleles of rs1400986 and
rs4129024 tSNPs. The SNP-based model provided the best fitting
model (p = 3.2E25; Table 2), indicating independent contribu-
tions to risk from these two SNPs, with no interactions between
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them. The haplotype of risk alleles [G-T] at rs4129024 and
rs1400986 confers an OR of 2.19 for sJIA (95% CI: 1.55–3.10;
p = 5.6E206) compared to the lowest-risk alleles [A-C] (Figure 4);
G-T had a frequency of 19% in sJIA cases compared to 12% in
WTCCC2 controls.
Persistent Oligoarticular JIA [pOJIA]
No SNP showed significant evidence for association for pOJIA
in the analysis of genotyped tSNPs (Table 1). In the imputation
analysis, one SNP in IL20 and five SNPs in (or near) IL-24
exceeded the p-value threshold adjusted for multiple testing of
imputed SNPs. However these SNPs are all rare (with imputed
frequency ,0.001). The Rsq quality metric for imputation in
MACH was ,0.4 which exceeded our chosen threshold of 0.3 but
reflects the difficulty in imputing rare variants that are only weakly
tagged by the genotyped SNPs. Full results of the imputation
analysis in this region are included in Supplementary Table S1.
Penalised logistic regression identified 14 SNPs (all imputed) in the
mode with highest log-posterior. The retained SNPs were those in
the IL-4 region showing significance above region-wide thresholds,
and additional SNPs located in the FAIM3-PIGR-FCAMR region
with lower association p-values (Supplementary Figure S2).
Exploratory haplotype analysis was performed, initially condi-
tioning on tSNP rs1878672 in intron 3 of IL-10, which showed the
strongest association with pOJIA (p= 0.0443). Conditioning on
this tSNP, three further tSNPs (rs3860300, rs1150258, and
rs291084) reached suggestive evidence for association
(p,0.0189; Figure 3). These tSNPs are all located in the IL-24/
FAIM3 region and in strong LD with each other, but not with
rs1878672 (all pairwise r2..85, see Supplementary Figure S1).
The conditional analysis on rs1878672 substantially increased the
evidence for association at these tSNPs, since none achieved even
nominal association when analysed singly (Table 1). When
conditioning on rs1878672 and rs291084, there was additional
evidence for association below suggestive p-value threshold at
rs4845121, which is located 139 Kb downstream of IL-10 in the
promoter region of the DYRK3. Conditional analysis of these three
tSNPs identified no further associations. Haplotype analysis of
these SNPs (rs4845121–rs1878672–rs291084) showed several
haplotypes with elevated risk. The highest risk was for a C-G-C
haplotype conferring an OR of 6.25 (95% CI: 2.76–14.19)
compared to the lowest-risk haplotype [G-C-C] under the full
haplotype model (p = 0.0002; Figure 4). The frequency of the C-
G-C haplotype was higher in cases (6%) than controls (2%).
Extended Oligoarticular JIA [eOJIA]
No SNP showed association meeting the Bonferroni threshold
for significance in eOJIA, with the strongest evidence for
association occurring at tSNP rs10863962 in FCAMR
(p = 0.0022; Table 1). As for sJIA, the imputation analysis did
not for any SNP reached significance at the region-wide p-value
(Figure 2; Supplementary Table S1). Penalised logistic regression
retained 14 SNPs (all imputed) in the resulting mode (Supple-
mentary Figure S2), but the same log-posterior of the mode was
observed for several combinations of retained SNPs.
Conditional analysis on the most significant tSNP (rs10863962)
reduced the evidence for association at SNPs in MAPKAPK2 and
around FCAMR/C1orf116, but there was an increase in signifi-
cance level to above suggestive threshold for one tSNP,
rs12409577, located in the intron of IL-19 (Figure 3). A
Figure 1. Single point results for sJIA, pOJIA, and eOJIA. Point colours indicate the different JIA subtypes. Thresholds are indicated for
nominal (p = 0.05) and region-wide significance (p = 0.00166).
doi:10.1371/journal.pone.0047673.g001
Association of IL-10 Gene Family with JIA
PLOS ONE | www.plosone.org 3 October 2012 | Volume 7 | Issue 10 | e47673
conditional analysis on rs10863962 and rs12409577 detected no
additional evidence for association. The full haplotype model in
UNPHASED gave for these two tSNPs (p = 0.0003) fitted
significantly better than the SNP model (Table 2). Under this
model the combination of the risk alleles [T-T] resulted in an
OR=3.40, (95% CI 2.01–5.61; p= 7.35E25 compared to the
lowest-risk haplotype [A-C] (Figure 4). The frequency of the [T-T]
haplotype was higher in cases (9%) than controls (3%).Our
previous disease association study revealed a significant increase in
the frequency of the homozygote genotype (ATA/ATA) of IL-10
haplotype A-T-A (rs1800896–rs1800871–rs1800872) in 78 pa-
tients with eOJIA compared to 86 pOJIA [7]. In this current
study, only rs1800896 and rs1800871 were typed, since rs1800872
is in complete LD with rs1800871. We did not observe a
significant difference in the frequency of single alleles, the 2-
marker A-T (rs1800896–rs1800871) or genotype distribution
between patients with oligoarticular JIA when compared with
controls. However, the frequency of the homozygote AT/AT
genotype was higher in eOJIA (7.2%) than pOJIA (3.7%) as
previously reported. The numbers of patient possessing the AT/
AT homozygous genotypes were too small for statistical analysis.
Association of Genotype with Gene Expression
We used the publicly available lymphoblastoid expression data
with HapMap genotypes [11] to obtain preliminary functional
information on the effect of tSNPs on mRNA expression, for 10
tSNPs with high risk of disease alleles (OR .1) from the single
SNP analysis (Table 1). The result of linear regression analysis
between the tSNP and HapMap expression data are shown in
Table 3. The tSNPrs4129024 showed a significant correlation
between genotype and expression of a MAPKAPK2 isoform
(NM_004759; p= 0.0027). The G allele has decreased expression
of this MAPKAPK2 isoform, and shows some evidence of increased
risk of sJIA (p = 0.0027; Table 1). No other SNPs tested for
expression reached the Bonferroni corrected p-value threshold,
but several SNPs showed nominal evidence of significance
(p,0.05; Table 3).
Discussion
This study has performed an in depth candidate region analysis
of the IL10 gene family in JIA subtypes. In the era of genome wide
association studies (GWAS), there is still a place for the
comprehensive mapping exercise reported here, as the density of
genotyped SNPs exceeds that available in most genome wide
chips, including ones employed in GWAS of JIA [12]. Fine
mapping of the IL-10 gene family has led to the identification of
novel genes associated with subtypes of JIA. Since it is known that
the tagging method performs poorly in predicting rare variants
[13], we additionally explored the genomic region through
imputation and through haplotype based and also penalized
logistic regression based analyses. These analyses enable us to
explore the hypothesis of ‘‘synthetic association’’ [14,15], where
signals of common non-functional SNPs outside of coding regions
of a candidate gene may be the result of a combination of rare
coding/functional variants with stronger effects present on the
haplotype. Other studies have obtained stronger association
signals upon combining tSNPs identified after conditioning on
the primary signal, as carried out in this study, suggesting
Table 1. Results of single point analysis for JIA subtypes and 5723 WTCCC2 controls, showing tSNPs associated at p,0.05.
MAF=minor allele frequency.
WTCCC sJIA (N=219) pOJIA (N=187) eOJIA (N=139)
SNP gene allele MAF freq* p OR 95% CI freq* p OR 95% CI freq* p OR 95% CI
rs7549114 DYRK3 A,G 0.15 0.15 0.8201 1.03 [0.79;1.35] 0.14 0.5107 0.90 [0.67;1.22] 0.10 0.0445 0.67 [0.46;0.99]
rs4129024{ MAPKAPK2 A,G 0.23 0.17 0.0027 0.68 [0.53;0.88] 0.21 0.4173 0.90 [0.7;1.16] 0.23 0.8837 0.98 [0.74;1.3]
rs4240847 MAPKAPK2 C,A 0.27 0.21 0.0103 0.74 [0.58;0.93] 0.26 0.9016 0.99 [0.78;1.25] 0.26 0.7493 0.96 [0.73;1.26]
rs4311892{ MAPKAPK2 G,A 0.26 0.27 0.4342 1.09 [0.88;1.35] 0.27 0.5169 1.08 [0.86;1.36] 0.32 0.0092 1.40 [1.09;1.82]
rs1878672{ IL10 G,C 0.48 0.53 0.0229 1.25 [1.03;1.51] 0.53 0.0443 1.24 [1.01;1.52] 0.51 0.2600 1.15 [0.9;1.46]
rs1800896{ IL10 A,G 0.48 0.53 0.0253 1.25 [1.03;1.51] 0.53 0.0610 1.22 [0.99;1.5] 0.51 0.2723 1.14 [0.9;1.45]
rs10494879 IL10 G,C 0.45 0.39 0.0188 0.79 [0.65;0.96] 0.41 0.1690 0.86 [0.7;1.07] 0.41 0.2987 0.88 [0.69;1.12]
rs4072226 IL10 T,C 0.45 0.40 0.0389 0.81 [0.67;0.99] 0.41 0.1439 0.86 [0.69;1.06] 0.41 0.2653 0.87 [0.68;1.11]
rs2981572‘ IL20 G,T 0.37 0.44 0.0018 1.36 [1.12;1.65] 0.40 0.1785 1.16 [0.94;1.43] 0.39 0.4301 1.10 [0.86;1.41]
rs1400986{ IL20 T,C 0.15 0.21 0.0004 1.53 [1.21;1.93] 0.17 0.2477 1.17 [0.89;1.54] 0.19 0.0766 1.32 [0.97;1.78]
rs10863962{ FCAMR T,C 0.26 0.32 0.0137 1.30 [1.05;1.59] 0.28 0.4465 1.09 [0.87;1.38] 0.35 0.0022 1.48 [1.15;1.9]
rs2000059 FCAMR A,G 0.11 0.11 0.8961 1.02 [0.75;1.39] 0.09 0.2895 0.82 [0.57;1.18] 0.07 0.0295 0.59 [0.36;0.95]
rs2353550{ FCAMR G,A 0.43 0.48 0.0185 1.26 [1.04;1.52] 0.45 0.3547 1.10 [0.9;1.36] 0.48 0.0680 1.25 [0.98;1.58]
rs2842711{ FCAMR T,A 0.35 0.39 0.0627 1.21 [0.99;1.47] 0.37 0.4308 1.09 [0.88;1.35] 0.42 0.0103 1.37 [1.08;1.74]
rs2791708 FCAMR C,T 0.36 0.39 0.1229 1.17 [0.96;1.42] 0.38 0.3414 1.11 [0.9;1.37] 0.42 0.0233 1.32 [1.04;1.68]
rs2842721{ C1orf116 A,G 0.23 0.23 0.9007 1.02 [0.81;1.27] 0.21 0.3928 0.90 [0.7;1.15] 0.31 0.0025 1.49 [1.15;1.93]
rs12409177 C1orf116 T,C 0.15 0.16 0.5817 1.08 [0.83;1.4] 0.14 0.9408 0.99 [0.74;1.33] 0.20 0.0155 1.45 [1.07;1.95]
rs12138969{ C1orf116 A,G 0.15 0.15 0.7951 1.04 [0.79;1.35] 0.14 0.9214 0.99 [0.74;1.32] 0.20 0.0165 1.44 [1.07;1.94]
Significant evidence of association was detected at rs1400986 for sJIA.
*Allele frequencies of the first allele (minor allele) is indicated.
‘rs2981572 is from PGA.
{tSNPs examined for correlation between lymphoblastoid mRNA expression and HapMap genotypes.
doi:10.1371/journal.pone.0047673.t001
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Figure 2. Imputation analysis for sJIA, pOJIA, and eOJIA, showing nominal (p =0.05) and region-wide significance at p=00016. For
imputed SNPs a cut-off of Rsq .0.3 was used (see text).
doi:10.1371/journal.pone.0047673.g002
Table 2. Conditional analysis, conditioning on the SNP with the strongest evidence of association, and adding additional SNPs
into the model.
JIA sub- Conditioning SNPs Most significant SNP(s) SNP p-value in Final model p-values
phenotype
conditioning
model
Haplotype
model
SNP model (joint
effect)
sJIA – rs1400986 0.0004 – –
rs1400986 rs4129024 0.0122 – –
rs1400986–rs4129024 – – 0.0001 (0.00014) 3.2e205 (4e205)
pOJIA – rs1878672 0.0443 – –
rs1878672 rs3860300 0.0123 – –
rs1150258 0.0103 – –
rs291084 0.0095 – –
rs1878672–rs291084 rs4845121 0.0068 – –
rs1878672–rs291084–rs4845121 – – 0.0018 (0.00184) 0.0453 (0.04077)
eOJIA – rs10863962 0.0022 – –
rs10863962 rs12409577 0.0090 – –
rs10863962–rs12409577 – – 0.0003 (0.00025) 0.0014 (0.00156)
For each JIA subtype, the most significant SNP from single point analysis (Table 1) was used to start the conditional analysis, and then the most significant SNP
achieving at least suggestive significance (p,0.0189) was added into the conditional model until no further SNPs were identified. In parentheses are reported the
empirical p-values obtained by running 100,000 permutations.
doi:10.1371/journal.pone.0047673.t002
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underlying, unidentified variant(s) that contribute to susceptibility
in the region [16].
In this JIA study, we have evidence from conditional analysis in
sJIA that there are likely to be multiple variants contributing to
susceptibility: one in IL-20 and another in MAPKAPK2. For
persistent oligoarticular JIA, we observed that nominal evidence
for association with rs1878672 (intron 3 of IL-10) is increased
when considered in a 3-marker haplotype analysis. In the case of
eOJIA, variants in 2 regions appear to contribute to susceptibility
(IL-19 and FCAMR/C1orf116), with some evidence of a haplotype
effect across SNPs. Results from the HyperLasso method, that
implements a penalised logistic regression analysis, also showed
that subsets of SNPs were associated with the different JIA
subtypes. Comparing results across these analyses is difficult since
the methods are so different, but both analyses indicate that there
is a complex pattern of genetic susceptibility to JIA in this region.
A major limitation of our study is that only modest sample sizes
of cases can be obtained for this rare, heterogeneous disease, and
we are further hindered by the lack of replication cohort. The
study design focused on obtaining the largest possible sample size
to detect association in a hypothesis-generating study, and further
studies will need to be performed to refute or to confirm the
associations detected here. An additional limitation of this study is
that the identification of tSNPs and SNPs tagged was done
predominantly through the use of HapMap and thus the
experimental design relies on the completeness of the data. 1000
Genomes imputation showed higher association signals that
exceeded the significance thresholds for pOJIA, but with relatively
low imputation quality reflecting the difficulty in imputing rare
variants that are only weakly tagged by the genotyped SNPs.
These results indicate that the haplotype associations identified in
this study are not due to a SNP present in 1000 Genomes
imputation analysis but untyped in our present study. Full
sequencing of the region in cases and controls will be needed to
be performed in order to identify all the variations present in this
region.
This study supports our previous finding of significant
association of a genetic variant of IL-20 with sJIA in a cohort of
twice the previous cohort size, indicating that this cytokine is
biologically important in this disease. It is known that IL-20 is a
potent inflammatory cytokine whose expression can be induced by
IL-1b through both p38 MAPK and NF-kB activity [17], and IL-
1ß is implicated in pathogenesis of sJIA [18]. The expression of IL-
20 mRNA is predominantly by keratinocytes [19] and activated
monocytes [20,21]. This cytokine has been found to be increased
in other inflammatory diseases. High IL-20 mRNA level is found
in the skin of patients with psoriasis [19,22] and the protein level is
high in synovial fluid from patients with rheumatoid arthritis [23].
Other studies have also suggested a potential role of IL-20 in
atherosclerosis and angiogenesis [24,25]. Overexpression of IL-20
in mice is lethal secondary to defective skin formation and poor
development of lymphoid tissue [26]. Our finding that there is
increased risk with the haplotype containing variants of IL-20 and
MAPKAPK2 suggests that IL-20 might have interdependent
biological activity with MAPKAPK2 that contribute to disease
susceptibility or severity. MAPKAPK2 is a Ser/Thr protein kinase
that is activated through direct phosphorylation by p38 MAP
kinase. IL-1b signals through the p38 pathway to induce IL-20
expression, via MAPKAPK2 and other signaling molecules, and so
genetic variants in these two genes can determine the final
outcome of an IL-1ß signal.
Many genetic associations of IL-10 SNPs have been reported in
the literature. A number of SNPs in IL-10 have been associated
with various inflammatory and autoimmune diseases including
Behcet’s disease [27], non-infectious uveitis [28], severity of
Rheumatoid Arthritis [29], and Type 1 diabetes [30]. The
significant tSNPs found in this study for IL-10 are located within a
well characterised co-coordinately regulated locus containing
several DNase hypersensitive sites identified in murine T cell
populations and bone marrow-derived macrophages [6,31].
Therefore the findings of haplotype association within the IL-10
gene locus as well as association of some of the SNPs with lower
expression are interesting, and further work is needed to see if
these contribute significant risk.
Two IL-10 genetic variants (rs1878672 and rs1800896) showing
some evidence of association with sJIA and pOJIA at single point
analysis decreased IL-10 mRNA expression as suggested by data
obtained from the gene expression HapMap database. This
biological function suggests that the associations of these variants
with disease are less likely to be false positives. However, functional
extrapolation from expression databases should be interpreted
contextually, taking into account that the expression data is for B
cells and the genotype data is from four different populations.
Tissue specific expression will need to be explored once we have
identified the real disease associated gene variants from sequenc-
ing.
Of great interest is that fine mapping of the extended IL-10 gene
family region revealed for the first time association of eOJIA with
tSNPs from regions surrounding FCAMR and C1orf116, an
interesting region where chromatin modeling activity has been
described by the ENCODE (EnCyclopedia of DNA Elements)
project (available on UCSC genome browser). In addition, we
have shown some evidence that tSNPs rs10863962 and rs2353550
increases FCAMR mRNA expression in transformed B cells from
HapMap expression database, suggesting functional roles for the
associated genetic variants.
In summary, we have applied three different statistical methods
to this data set (single SNP analysis, HyperLasso, haplotype
analysis), each having different strengths with the aim of
optimising our ability to determine the genetic architecture of
JIA in the IL10 region. None of these approaches produced highly
significant results or easily interpretable results apart from the
single point association with IL-20 in sJIA, and larger sample sizes
will be needed to follow up on these findings. Despite these
caveats, we have observed differences in the association of IL-10
gene family with subtypes of JIA. We have provided supporting
evidence for previous published associations of genetic variants
with sJIA. We have shown that haplotype analyses provide
stronger signals than single point analysis which is consistent with
synthetic association [15]. The identification of rare, risk
haplotypes represents only one possibility for synthetic association
and direct sequencing must be performed to explore this further.
This comprehensive candidate gene association study covering
all known SNPs with the tSNP approach is the first to be
Figure 3. Conditional analysis on the most significant SNPs for each JIA subtype. For each SNP, the square represents the p-value after
adjusting for the effect of the conditioned SNP, while the other end of the line shows the p-value of a single-locus analysis, prior to conditioning.
Colours show the range of r2 between the conditioned SNP and the tested SNP as indicated in the insert. Location of the conditioned SNPs is
indicated by a black square. Thresholds are indicated for nominal (p = 0.05), suggestive (p = 0.0189) thresholds, with tSNPs above suggestive
threshold indicated in bold.
doi:10.1371/journal.pone.0047673.g003
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performed for the IL-10 family, in the largest cohort of a rare
disease. It has revealed biologically relevant novel genetic
associations that will require further characterisation with gene
sequencing to identify the real disease associated genetic varia-
tions.
Materials and Methods
Ethics Statement
Ethical approval for the study was obtained from Great
Ormond Street Hospital for Children NHS Trust and Institute
of Child Health, Research Ethics Committee (reference 02RU06
and 04RU07 (05/Q0508/95)) and parents provided written
informed consent.
Patient and Control Samples
Patients with JIA were included from Great Ormond Street
Hospital (GOSH), University College London Hospital, Wexham
Park Hospital, the British Society for Paediatric and Adolescent
Rheumatology (BSPAR) National Repository for JIA and the
Childhood Arthritis Prospective Study (CAPS) repository, both
housed at the Arthritis Research UK Epidemiology Unit in
Manchester, and the SPARKS Childhood Arthritis Response to
Medication (CHARMS) study housed at the UCL Institute of
Child Health, London. Patients were classified according to the
criteria of the International League of Associations for Rheuma-
tology [1]. The sJIA patients in this present study are an expanded
population containing 122 patients (55.7%) from Fife et al [9]. The
oligoarticular JIA samples are a different cohort from patients
previously studied by Crawley et al [7].
Genotype data for the control population was downloaded from
the WTCCC web site at http://www.wtccc.org.uk [32]. After
matching and removing duplicated individuals, the WTCCC2
cohorts comprised 2889 samples from the 1958 British Birth
Cohort (1958BC) and 2834 samples from the UK Blood Services
collection (NBS) that were used as our controls. They were
genotyped on both the Illumina 1.2 M Duo (Human1-2M-
DuoCustom_v1) chip and the Affymetrix v6.0 chip.
Selection of Tagging SNPs for Typing
We used two data sources in order to obtain thorough SNP
coverage of the candidate genes: 1) the International HapMap
project [33] for the CEPH (Utah residents with ancestry from
northern and western Europe) population (HapMap data release
#24/phaseII Nov07, on NCBI B36 assembly, dbSNPb126) and 2)
the population of European descent from SeattleSNPs which is
part of the NHLBI Programs for Genomic Applications (PGA)
(www.nhlbi.nih.gov/resources/pga) that have re-sequenced genes
underlying inflammatory diseases in humans. We used the
Haploview programme (version 3.2) [34] to calculate linkage
disequilibrium between SNPs with minor allele frequency (MAF)
of 0.1. We then selected SNPs that tagged other SNPs with the
criteria of minimum r2 value of 0.8. The selected SNP set with
successful assay design consisted of 68 tSNPs that captures 290
SNPs spanning the region 204868570–205258803 bp (390.2 Kb)
of chromosome 1. The cut-off for this region was chosen at the end
of a block of linkage disequilibrium (LD) that also corresponded to
region of conserved sequences between different mammals
identified using homology VISTA plots. The rationale for
inclusion of conserved regions is that such regions can contain
Figure 4. Odds ratios for each haplotype in the best-fitting
model for each JIA subtypes, with 95% CI (grey band, with
width proportional to haplotype frequency in controls).
doi:10.1371/journal.pone.0047673.g004
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important regulatory elements for the genes. As a result of this
approach, 6 flanking genes that are not members of IL-10 gene
cluster were also included: dual-specificity tyrosine-(Y)-phosphor-
ylation regulated kinase 3 (DYRK3), mitogen-activated protein
kinase-activated protein kinase 2 (MAPKAPK2), both located
downstream of IL-10, and Fas apoptotic inhibitory molecule 3
(FAIM3), polymeric immunoglobulin receptor (PIGR), receptor for
Fc fragment of IgA and IgM (FCAMR), and chromosome 1 open
reading frame (C1orf116) all upstream of IL-10.
Genotyping
Genotyping of the cases in this study was performed with the
Illumina GoldenGate assay genotyping platform (custom 384 SNP
panel, 96-sample Sentrix array matrix). To check the quality of the
genotyping, automatic clustering of the samples and genotype
calling was done with the Illumina BeadStudio software (version
3.2.23) and confirmed independently by two investigators.
Duplicates of 28 individuals were included for quality control
purposes.
Association Analysis
Single point, allelic association analysis of the genotyping data
was performed using the software PLINK [35], conditional and
haplotype analyses were performed with the software UN-
PHASED [36].
Imputation analysis, based on the 1000 Genomes Project data
(Interim Phase I Haplotypes; 2010–11 data freeze; 2011-06
haplotypes), was carried out using the phased data generated at
the Baylor College of Medicine. This release includes haplotypes
for a total of 1,094 individuals, from which we used in our analysis
the 381 Caucasian. Data for the chromosome 1 region of interest,
plus additional 250 Kb on each side (206551.9–207442.2 Kb,
based on Build 37) were extracted, for a total number of 10,765
SNPs present in the region (http://www.sph.umich.edu/csg/
abecasis/MACH/download/1000G-PhaseI-Interim.html).
We performed genotype imputation using a hidden Markov
model algorithm implemented in MACH software version 1.0
[37,38]. Parameters for the hidden Markov model for imputation
were first estimated in the reference set, and then all individuals
were imputed based on those parameters. A dosage score (ranging
from 0 to 2) was computed at each SNP for each individual, which
is the expected number of copies of a given allele conditional on
the genotypes of directly assayed SNPs and integrating overall
possible configurations of the phased reference haplotypes. Test
for association were carried out using mach2dat that performs
logistic regression using imputed SNP dosage data. Only those
SNPs with a predicted imputation quality (Rsq) value of at least 0.3
were considered, resulting in 1,327 SNPs.
In order to identify a subset of SNPs that best predicts disease
status among all imputed and typed SNPs, we run HyperLasso
that implements an algorithm for finding approximate modes of a
penalised likelihood function for linear or logistic regression [39].
HyperLasso is useful when there are many more predictors than
observations, because the penalty function can overcome the
problem of over-fitting that would undermine any usefulness of
standard logistic regression. The method selects a subset of SNPs
that best predicts disease status, while controlling the type-I error
of the selected SNPs. We used the Normal-Exponential-Gamma
(NEG) probability density penalty function and the values of the
shape and scale parameters were determined by a permutation
strategy (100 iterations), as in Vignal et al [40] in order to identify
the largest posterior mode within each dataset. This method
Table 3. Linear regression analysis between tSNPs and HapMap lymphoblastoid cell line expression levels of MAPKAPK2, IL-10, IL-
20, FCAMR and C1orf116.
Gene Significant tSNP Location
Disease Associated
allele*
Effect on Expression
level
Linear regression
p-value{
MAPKAPK2 (NM_004759){ rs4129024 Intron 1 G Decreased 0.003
rs4311892 3.94 kb
downstream
G No effect 0.193
MAPKAPK2 (NM_032960){ rs4129024 Intron 1 G No effect 0.066
rs4311892 3.94 kb
downstream
G No effect 0.055
IL-10 rs1878672 Intron 3 G Decreased 0.022
rs1800896 21082 bp A Decreased 0.011
IL-20 rs1400986 2468 bp T No effect 0.404
FCAMR rs10863962 2.24 kb
downstream
T Increased 0.009
rs2353550 23.34 kb
upstream
G Increased 0.005
rs2842711 215.19 kb
upstream
T No effect 0.655
C1orf116 rs2842721 3.66 kb
downstream
A No effect 0.187
rs12138969 705 bp
downstream
A No effect 0.609
*Allele with increased frequency in children with JIA compared with controls. This corresponds to the minor alleles for all except rs4129024 where the frequency of
major allele G is higher in cases than controls.
{Two transcript encoding two different isoforms have been found for this gene. They code for the same number of exons but differ at the 39UTR region.
{The linear regression model was used to evaluate the association between log2-transformed expression values and genotypes of tSNPs. Associations reaching nominal
significance (p,0.05) are shown in bold. One SNP reached the Bonferroni corrected threshold for 12 tests of 0.0042 = 0.05/12.
doi:10.1371/journal.pone.0047673.t003
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avoids some of the pitfalls of forward- or backward selection
methods but despite its statistical strengths it has not yet been
widely applied in genetic studies.
Finally, to explore more complex patterns of association with
SNPs that are poorly tagged by tSNPs, an iterative conditional
analysis procedure was implemented for each JIA subtype. This
strategy distinguishes between tSNPs showing association through
LD and builds multi-SNP models where SNPs contributing
independent association signals. Conditional analysis uses a
baseline model of specific SNP, then tests whether including an
additional SNP in the model significantly improves fit of the
model. The method therefore assesses whether the additional SNP
contributes further information for association, after the associa-
tion at the first SNP (or SNPs) is accounted for. For the first
conditional analysis, we conditioned on the tSNP with the
strongest evidence of association, testing all other tSNPs for
association in the presence of this tSNP. If any tSNPs achieved
suggestive significance (p#0.0189, see below), the most significant
of these tSNPs was included in the conditional part of the model,
and the analysis repeated to identify any further tSNPs contrib-
uting independent association effects. This procedure was repeated
until no tSNP achieved suggestive significance threshold. For
tSNPs included in the final model, we tested the fit of a SNP model
(a joint effect, assuming independent contributions to risk from
each tSNP), and a haplotype model, where interactions between
SNPs are modelled.
Conditional analysis was performed in UNPHASED [35] under
a full haplotype model omitting rare haplotypes with frequency
,1%. This model estimates separate risk effects (OR) for each
haplotype, and gives a p-value for the improvement in fit of the
model with the additional SNP, compared to the baseline model
containing only conditional SNP(s). For tSNPs in the final
conditional analysis, the SNP-based model was fitted using ‘allele
main effect’ model in UNPHASED, which constrains the
haplotype effect to be equal to the product of effect for each
tSNP allele. To determine the most parsimonious well-fitting
model, we tested for a significant difference in fit between the
haplotype model (degrees of freedom=number of haplotypes 21)
and the SNP model (degrees of freedom=number of SNPs 21).
Empirical p-values were also calculated for haplotype-based tests
by running 100,000 permutations generated by randomly shuffling
the affection status between cases and controls with UNPHASED.
Significance Levels Accounting for Multiple Testing
Applying an appropriate correction for multiple testing is
essential for a candidate gene study to be interpreted correctly. In
this study, levels of significance were applied as appropriate for the
different analysis strategies used. For the single-point analysis of 53
SNPs, Nyholt’s method [10] was used to calculate the effective
number of tests within the region based on the LD pattern in the
WTCCC2 controls. The 53 tSNPs were equivalent to 30.9
independent tests, and a Bonferroni corrected p-value is then
calculated from 0.05/30.9 = 0.00166. A similar method was
applied in the imputation analysis; imputed SNPs gave an
equivalent of 320 independent tests and a p-value of 0.00016.
For the exploratory conditional analysis, no equivalent method
to determine appropriate correction for multiple testing is
available. The most significant SNP from each JIA sub-phenotype
was used to seed the conditional analysis. Additional SNPs were
added in an iterative procedure if they achieved a threshold of
suggestive significance, the level expected to arise once in the
analysis of 53 SNPs in this region, with p= 0.0189= 1/53.
Correlation of Genotype with Gene Expression
We investigated the relationship between mRNA expression
and genotype from the transformed B-cell lines dataset generated
from a large number of unrelated HapMap individuals [11].
Statistical analysis was performed in SPSS using linear regression
to evaluate the association between normalized log2-transformed
gene expression values and genotypes of 10 tSNPs with high risk of
disease alleles (OR .1) from the single SNP analysis (Table 1). A
Bonferroni correction was applied to determine significant
correlation between genotype and gene expression correcting for
12 analyses, giving a significance threshold of p,0.0042 (two
isoforms were available for MAPKAPK2).
Supporting Information
Figure S1 LD pattern in the WTCCC2.
(PNG)
Figure S2 Results of penalised logistic regression using
HyperLasso program for typed and imputed SNPs for
sJIA, pOJIA, and eOJIA. HyperLasso-detected SNPs are
highlighted (HLasso in ‘‘red’’).
(TIF)
Table S1 Results of the imputation analysis. Only SNPs
showing at least suggestive significance in any of the
sub-phenotypes are shown. In bold are indicated
significant SNPs.
(DOC)
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